Vimarsana
Biggest News Aggregation in the World

Bcbsm Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bcbsm Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bcbsm Inc Today - Breaking & Trending Today

Net Lease Office Properties Announces Sales of Four U.S. Office Properties Totaling $43 Million - Vimarsana News

Net Lease Office Properties Announces Sales of Four U.S. Office Properties Totaling $43 Million

/PRNewswire/ -- Net Lease Office Properties (NYSE: NLOP) today announced the sale of the following four U.S. office properties during December 2023 for gross...

Investegate |Indivior PLC Announcements | Indivior PLC: 1st Quarter Results - Vimarsana News

Investegate |Indivior PLC Announcements | Indivior PLC: 1st Quarter Results

Investegate announcements from Indivior PLC, 1st Quarter Results

Robins Kaplan LLP Announces a Class Action Settlement for Third Party-Payors that Made Payments or Provided Reimbursement for the Drug Daraprim from August 7, 2015 through January 28, 2022 - Vimarsana News

Robins Kaplan LLP Announces a Class Action Settlement for Third Party-Payors that Made Payments or Provided Reimbursement for the Drug Daraprim from August 7, 2015 through January 28, 2022

/PRNewswire/ -- Legal Notice If you are a Third-Party Payor and made payments or reimbursements for some or all of the purchase price of Daraprim from August...

Robins Kaplan LLP Announces a Class Action Settlement for Third Party-Payors that Made Payments or Provided Reimbursement for the Drug Daraprim from August 7, 2015 through January 28, 2022 - Vimarsana News

Robins Kaplan LLP Announces a Class Action Settlement for Third Party-Payors that Made Payments or Provided Reimbursement for the Drug Daraprim from August 7, 2015 through January 28, 2022

/PRNewswire/ -- Legal Notice If you are a Third-Party Payor and made payments or reimbursements for some or all of the purchase price of Daraprim from August...

Parties Argue Whether Court Should Remand, Transfer, or Toss Celgene Pay-for-Delay Case - Vimarsana News

Parties Argue Whether Court Should Remand, Transfer, or Toss Celgene Pay-for-Delay Case

Parties Argue Whether Court Should Remand, Transfer, or Toss Celgene Pay-for-Delay Case January 8, 2021 On Wednesday, Celgene Corporation and its parent Bristol Myers Squibb Company filed an opposition to the plaintiffs’ motion for remand in an antitrust lawsuit alleging that the defendants overcharged the plaintiffs for two cancer treatments, Revlimid and Thalomid. The defendants had previously asked for dismissal for failure to state a claim upon which relief can be granted, or in the alternative, transfer. Also on Wednesday, the plaintiffs, three affiliated health insurers and a fourth c...